In vitro tests indicated that because of enhancing the knockdown of the MDR gene, the aptamer-labeled P-gp siRNA-encapsulated NPs produced a greater cellular internalization and direct accumulation of drugs (doxorubicin) in the nuclear compartment of breast cancer cells, which allowed to overcome MDR phenomenon [160]. This evidence concerns the gene PGP and breast carcinoma.